Skip to main content
An official website of the United States government

Supportive Care and Symptom Management

The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Supportive Care and Symptom Management

The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).

Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience. 

Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.

Selected Topics

Funding Opportunities

No matching Funding Opportunities were found.

View All Funding Opportunities

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Kresty, Laura A

University Of Michigan At Ann Arbor
United States

Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma 1UG3CA299397-01 Altaf Mohammed, Ph.D.
Krist, Alexander H

Virginia Commonwealth University
United States

Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) 3UG1CA287017-02S1 Elyse LeeVan, M.D., M.P.H.
Kroetz, Deanna L

Ohio State University
United States

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity 5R01CA261068-06 Rachel Altshuler, Ph.D.
Kroetz, Deanna L

Ohio State University
United States

Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity 5R01CA261068-06 Rachel Altshuler, Ph.D.
Kuhn, Peter

University Of Southern California
United States

Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma 4U01CA285013-03 Nicholas Hodges, Ph.D.
Kumar, Nagi B.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Phase II Clinical trial of GTC in Men on Active Surveillance 5R01CA235032-06 Howard L. Parnes, M.D.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck 5R33CA281802-03 Wendy Wang, Ph.D., M.Sc.
Labaer, Joshua

Arizona State University-Tempe Campus
United States

High-throughput immunoproteomics for cancer biomarker discovery 5U2CCA271903-04 Christos Patriotis, Ph.D., M.Sc.
Lampe, Paul D.

Fred Hutchinson Cancer Center
United States

Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer 5R01CA281801-03 Guillermo Marquez, Ph.D.
Langel, Stephanie N.

Case Western Reserve University
United States

Antibody bound bacteria during HPV infection and cervical dysplasia 3R21CA289927-02S1 Goli Samimi, Ph.D., M.P.H.
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP 3UG1CA189855-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Langevin, Anne-Marie R.

University Of Texas Hlth Science Center
United States

Texas Pediatric NCORP 3UG1CA189855-11S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Leal, Ana Sofia Mendes

Indiana University Indianapolis
United States

Nrf2, immune cells and lung cancer 7R01CA226690-06 Marjorie Perloff, M.D.
Lee, Jeffrey Kuang Zou

Kaiser Foundation Research Institute
United States

Vanguard Study Administrative Supplement 3UG1CA287011-02S1 Elyse LeeVan, M.D., M.P.H.
Lee, Hakho

Massachusetts General Hospital
United States

Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array 5U01CA284982-03 Nicholas Hodges, Ph.D.

Clinical Trials

Status

No matching Clinical Trials were found.

View All Clinical Trials